Global Ophthalmoplegia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Global Ophthalmoplegia Market is Segmented By Treatment Type (Drug Therapy, Surgical Therapy), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.
Global Ophthalmoplegia Market Size
Market Size in USD
CAGR7.5%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7.5% |
| Market Concentration | High |
| Major Players | Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG |
please let us know !
Global Ophthalmoplegia Market Analysis
The ophthalmoplegia market is estimated to be valued at USD 510 Mn in 2024 and is expected to reach USD 850 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
There is an increasing trend seen in the ophthalmoplegia market owing to rising cases of neurological disorders that often cause ophthalmoplegia. The growing geriatric population worldwide who are more prone to such neurological conditions is also contributing to the growth of this market. Moreover, development of advanced treatment options and improving healthcare infrastructure in developing nations have helped in greater diagnosis of ophthalmoplegia cases thereby spurring market revenues.